Hosted on MSN

Alleviant Medical wins IDE for no-implant atrial shunt device pivotal trial

The US Food and Drug Administration (FDA) has granted Alleviant Medical an investigational device exemption (IDE), enabling the company to begin a pivotal trial evaluating its atrial shunt ...
TCTMD

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

NEW ORLEANS, LA—A novel transcatheter intracardiac shunt device appears to provide sustained clinical benefit at 1 year in heart failure patients with preserved or only mildly reduced ejection ...
MedPage Today

HF Shunt Results Hold Up Midterm in Early Data

PHOENIX -- The functional and quality-of-life benefits of creating a left-to-right shunt in the interatrial septum to offload failing hearts held up over the midterm in a series of small feasibility ...
TCTMD

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Placement of an atrial shunt device intended to reduce pulmonary capillary wedge pressure (PCWP) during exercise in patients with heart failure and preserved ejection fraction (HFpEF) does not reduce ...
Yahoo Finance

Collaboration between Medical Device Companies and Healthcare Institutions is Contributing to the Growth of the Hydrocephalus Shunt Market As per Future Market Insights, Inc.

NEWARK, Del, Feb. 20, 2024 (GLOBE NEWSWIRE) -- According to Future Market Insights’ latest industry analysis, the Hydrocephalus Shunt Market size is estimated to be around US$ 546.09 million in 2024.
Healio

REDUCE LAP-HF: Interatrial shunt device lowers left atrial pressure in HFpEF

Please provide your email address to receive an email when new articles are posted on . ANAHEIM, Calif. — A transcatheter interatrial shunt device reduced pulmonary capillary wedge pressure during ...